 The most clinically relevant interactions have been associated with the lipid lowering drugs statins, which led to the removal of cerivastatin from the market in 2002.Single nucleotide polymorphisms (SNPs) are also associated with the OATPs; particularly OATP1B1.Many modulators of OATP function have been identified based on in vitro research in OATP-transfected cell lines.